Quick Answer
Nanobiotix S.A. reported Total Assets of $67.76 million for fiscal year 2025.
Nanobiotix S.A. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $67.76M +0.5% |
$67.42M -28.2% |
$93.90M +57.1% |
$59.77M -41.3% |
$101.77M -24.1% |
$134.03M +138.5% |
| R&D Expense | $23.11M -43.0% |
$40.54M +5.6% |
$38.40M +17.6% |
$32.64M +7.4% |
$30.38M +24.9% |
$24.33M -20.0% |
- Nanobiotix S.A. reported Total Assets of $67.76 million for fiscal year 2025.
- Nanobiotix S.A. showed an increase of +0.5% in Total Assets compared to the prior fiscal year.
- Nanobiotix S.A. reported R&D Expense of $23.11 million for fiscal year 2025.
- Nanobiotix S.A. showed a decrease of -43.0% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: